YPV-31004-68260
3 vaccinations
13 coded responses
23 check-ins
12 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 945 / CA
- Registered
- 2021-10-19
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-10-19
Registered in v-safe
-
2021-10-19
Dose 1 — Pfizer-BioNTechCo-administered: Flu
- 2021-10-19
-
2021-10-20
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-10-22
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-23
Health check-in — days 1–6 daily, dose 1Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-10-24
Survey response — days 1–6 daily, dose 1MedDRA: Asthma — Feeling: Fair · Joint painsFree text: Asthma in the morning afternoon and before bedMedDRA releases: 2024-11 · check-in free text available
- 2021-10-25
- 2021-10-28
-
2021-11-02
Survey response — day 14, dose 1MedDRA: Arthralgia, Middle insomnia — Feeling: GoodFree text: Forgot to mention this on last check ins unable to stay asleep at night/waking up in the middle of the night and being up for a while. Joint pain.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-09
-
2021-11-13
Dose 2 — Pfizer-BioNTech
-
2021-11-16
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness, Rhinorrhoea — Feeling: Fair · Site: Itching · Muscle or body achesFree text: Runny nose and dizzinessMedDRA releases: 2024-11 · check-in free text available
-
2021-11-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Redness, Swelling, Itching · Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
-
2021-11-19
Survey response — days 1–6 daily, dose 2MedDRA: Asthma — Feeling: Fair · Joint painsFree text: AsthmaMedDRA releases: 2024-11 · check-in free text available
-
2021-11-21
Survey response — day 7, dose 2MedDRA: Dizziness, Migraine — Feeling: Poor · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaFree text: Migraine, dizzinessMedDRA releases: 2024-11 · check-in free text available
-
2021-11-29
Survey response — day 14, dose 2MedDRA: Heart rate increased, Vomiting — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Increased heart rate and vomitingMedDRA releases: 2024-11 · check-in free text available
- 2021-12-04
-
2021-12-13
Survey response — day 28, dose 2MedDRA: Abdominal pain upper, Cough, Headache, Rhinorrhoea, Vomiting, Wheezing — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Wheezing, vomiting, stomach pains, cough, headache, runny noseMedDRA releases: 2024-11 · check-in free text available
-
2021-12-20
Survey response — day 35, dose 2MedDRA: Cough, Fatigue, Vomiting — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Vomiting. Cough. FatigueMedDRA releases: 2024-11 · check-in free text available
-
2021-12-25
Survey response — day 42, dose 2MedDRA: Nocturnal dyspnoea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Shortness of breath at night.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-05
Dose 3 — Pfizer-BioNTechCo-administered: HPV
-
2022-05-13
Survey response — day 7, dose 3MedDRA: Intermenstrual bleeding — Feeling: Good · Site: Itching · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to do your normal daily activitiesFree text: Menstrual spottingMedDRA releases: 2024-11 · check-in free text available
-
2022-05-21
Survey response — day 14, dose 3MedDRA: Fatigue — Feeling: FairFree text: FatigueMedDRA releases: 2024-11 · check-in free text available
-
2022-06-11
Survey response — day 35, dose 3MedDRA: Bronchitis — Feeling: Fair · Be unable to work or attend schoolFree text: BronchitisMedDRA releases: 2024-11 · check-in free text available
- 2022-08-04
-
2023-05-05
Survey response — 12 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-10-19 | Pfizer-BioNTech | Flu |
| 2 | 2021-11-13 | Pfizer-BioNTech | No |
| 3 | 2022-05-05 | Pfizer-BioNTech | HPV |
Free text
Release 10 — days 1–6 daily, dose 1
Systemic reaction (other): Asthma in the morning afternoon and before bed
Release 10 — day 14, dose 1
Symptoms: Forgot to mention this on last check ins unable to stay asleep at night/waking up in the middle of the night and being up for a while. Joint pain.
Release 10 — days 1–6 daily, dose 2
Systemic reaction (other): Runny nose and dizziness
Systemic reaction (other): Asthma
Release 10 — day 7, dose 2
Systemic reaction (other): Migraine, dizziness
Release 10 — day 14, dose 2
Symptoms: Increased heart rate and vomiting
Release 10 — day 28, dose 2
Symptoms: Wheezing, vomiting, stomach pains, cough, headache, runny nose
Release 10 — day 35, dose 2
Symptoms: Vomiting. Cough. Fatigue
Release 10 — day 42, dose 2
Symptoms: Shortness of breath at night.
Release 11 — day 7, dose 3
Systemic reaction (other): Menstrual spotting
Release 11 — day 14, dose 3
Symptoms: Fatigue
Release 12 — day 35, dose 3
Symptoms: Bronchitis
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal pain upper | · | · | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Bronchitis | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Heart rate increased | · | · | ✓ |
| SD | Middle insomnia | · | · | ✓ |
| SD | Nocturnal dyspnoea | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
| SD | Wheezing | · | · | ✓ |
| SRO | Asthma | · | · | ✓ |
| SRO | Dizziness | · | · | ✓ |
| SRO | Intermenstrual bleeding | · | · | ✓ |
| SRO | Migraine | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release